Skip to main content

Day: July 31, 2025

Gildan Reports Record Second Quarter Revenue and Adjusted Diluted EPS¹ and Updates its Full Year 2025 Guidance

(all amounts are in U.S. dollars except where otherwise indicated)(1) Please refer to “Non-GAAP financial measures and related ratios” in this press releaseRecord net sales of $919 million, up 6.5% vs. the prior year Operating margin of 21.7%, adjusted operating margin1 of 22.7% GAAP diluted EPS of $0.91 and record adjusted diluted EPS1 of $0.97 Cash flow from operations of $188 million and free cash flow1 of $154 million Capital returned to shareholders of $145 million through share repurchases and dividends Company reaffirms its full year 2025 guidance including the impact of tariffs, while narrowing its adjusted diluted EPS1 2025 guidance range Gildan recognized as one of the Best 50 Corporate Citizens in Canada by Corporate Knights and is once again included on TIME’s World’s Most Sustainable Companies...

Continue reading

Costamare Inc. Reports Results for the Second Quarter and Six-Month Period Ended June 30, 2025

MONACO, July 31, 2025 (GLOBE NEWSWIRE) — Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the second quarter and six-month period ended June 30, 2025. Discontinued operations as a result of Costamare Bulkers Holdings Limited Spin-Off The financial results for the three- and six-month periods ended June 30, 2025, reflect the spin-off of Costamare’s dry bulk business (consisting of Costamare’s dry bulk owned fleet and its dry bulk operating platform, Costamare Bulkers Inc. (“CBI”)) into a standalone public company, which was completed on May 6, 2025. Accordingly, the results of the dry bulk business are presented as discontinued operations for all periods shown. For the three- and six-month periods ended June 30, 2025, the results of discontinued operations include the dry...

Continue reading

CSW Industrials Reports Record Fiscal 2026 First Quarter Results

DALLAS, July 31, 2025 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (NYSE: CSW or the “Company”) today reported record results for the fiscal 2026 first quarter period ended June 30, 2025. Fiscal 2026 First Quarter Highlights (comparisons to fiscal 2025 first quarter)Total revenue increased 16.6% to a first quarter record of $263.6 million, driven by the recent acquisitions of Aspen Manufacturing, PSP Products, and PF WaterWorks Net income attributable to CSW of $40.9 million, increased 6.0% to a first quarter record, compared to $38.6 million Earnings per diluted share (“EPS”) of $2.43, decreased 1.9% when compared to $2.47 Adjusted EPS of $2.85, excluding the amortization of acquisition-related intangible assets, increased 2.5% when compared to $2.78 EBITDA grew 5.3% to a first quarter record of $68.7 million Paid...

Continue reading

Real Matters Reports Third Quarter Financial Results

(all amounts are expressed in millions of U.S. dollars, excluding per share amounts and unless otherwise stated) TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Real Matters Inc. (TSX: REAL) (“Real Matters” or the “Company”), a leading network management services platform for the mortgage and insurance industries, today announced its financial results for the third quarter ended June 30, 2025. “Consolidated revenues increased 22% sequentially in the third quarter to $45.4 million, in line with a seasonal uptick in U.S. Appraisal purchase mortgage market volumes and double-digit revenue growth in all three segments. We posted positive consolidated Adjusted EBITDA(A) of $0.3 million, up from a loss of $1.9 million in the second quarter of 2025,” said Real Matters Chief Executive Officer Brian Lang. “We continued to launch new clients in...

Continue reading

XPO Reports Second Quarter 2025 Results

GREENWICH, Conn., July 31, 2025 (GLOBE NEWSWIRE) — XPO (NYSE: XPO) today announced its financial results for the second quarter 2025. The company reported diluted earnings per share of $0.89, compared with $1.25 for the same period in 2024, and adjusted diluted earnings per share of $1.05, compared with $1.12 for the same period in 2024.Second Quarter 2025 Summary Results                                     Three Months Ended June 30,      Revenue   Operating Income (Loss)(in millions)     2025     2024   Change %     2025     2024   Change %North American Less-Than-Truckload Segment   $           1,240   $           1,272   -2.5%   $              199   $              203   -2.0%European Transportation Segment                  841                  808   4.1%                   11                   10   10.0%Corporate                   ...

Continue reading

WisdomTree Multi Asset Issuer PLC Restrike of WisdomTree Copper 3x Daily Leveraged

WisdomTree Multi Asset Issuer PLC LEI: 2138003QW2ZAYZODBU2331 July 2025 WisdomTree Multi Asset Issuer PLC(the “Issuer”)Restrike of WisdomTree Copper 3x Daily Leveraged(the “Impacted Product”) The Issuer announces that due to movements in the price of copper futures, a Restrike Event has occurred with respect to the Impacted Product. The details of the restrike are as follows:Start of Restrike Period: 10:00:00 (London time) on 31 July 2025 End of Restrike Period: 10:15:00 (London time) on 31 July 2025 Restrike Price per ETP Security: $ 8.5971241 Restrike threshold: 20% Index: Solactive HG Copper Commodity Futures SL IndexThe Restrike Price per ETP Security has been calculated based on the Restrike Index Level. Terms used in this notice and not otherwise defined bear the same meanings as where used in the base prospectus of the Issuer...

Continue reading

AMA: PBM Markets are at Risk of Harming Patients

New AMA analysis details low PBM competition, high vertical integration with insurers CHICAGO, July 31, 2025 (GLOBE NEWSWIRE) — The American Medical Association (AMA) today published a new annual analysis measuring competition in pharmacy benefit manager (PBM) markets and vertical integration of insurers with PBMs. The assessment demonstrates low competition in PBM markets across the nation and high vertical integration as the largest PBMs share ownership with health insurers. The AMA analysis adds to growing concern over anticompetitive harm resulting from low competition and high vertical integration in the PBM industry. It comes on the heels of reports by the Federal Trade Commission and U.S. House Committee on Oversight and Accountability finding that a handful of PBMs have vast power and control over medication access and...

Continue reading

Cenovus announces second-quarter 2025 results

CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced its second-quarter 2025 financial and operating results. The company generated approximately $2.4 billion in cash from operating activities, $1.5 billion of adjusted funds flow and $355 million of free funds flow. Total upstream production was 765,900 barrels of oil equivalent per day (BOE/d)1, reflecting planned turnarounds at the Foster Creek and Sunrise oil sands assets, maintenance at offshore facilities and short-term production impacts from wildfire activity at Christina Lake. Downstream crude throughput was 665,800 barrels per day (bbls/d), representing an overall utilization rate of 92% and including the successful completion of a turnaround at the Toledo Refinery 11 days ahead of schedule. HighlightsAchieved...

Continue reading

Crawford United Corporation Announces Second Quarter 2025 Results

Earnings per share of $1.44 for the quarter and $2.32 year-to-date Sales of $46.9 million for the quarter, an increase of 24.5% from the prior year quarter Net income of $5.1 million for the quarter and $8.3 million year-to-date EBITDA As Defined1 of $9.3 million for the quarter and $16.1 million year-to-dateCLEVELAND, July 31, 2025 (GLOBE NEWSWIRE) — Crawford United Corporation (OTC: CRAWA), a growth-oriented holding company serving diverse markets, today reported results for the quarter ended June 30, 2025. For the quarter ended June 30, 2025, sales were $46.9 million compared with $37.6 million in the same period in 2024, an increase of 24.5%. In the quarter, the Company recorded operating income of $7.3 million compared with operating income of $5.1 million in the same quarter of the prior year, an increase of 43.3%. Net income...

Continue reading

Integra LifeSciences Reports Second Quarter 2025 Financial Results

PRINCETON, N.J., July 31, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2025. Second Quarter 2025 HighlightsSecond quarter revenues exceeded guidance; adjusted earnings per diluted share (EPS) at the top end of the range Second quarter revenues of $415.6 million decreased (0.6)% on a reported basis and (1.4)% on an organic basis compared to the prior year. Second quarter GAAP earnings per diluted share of $(6.31), compared to $(0.16) in the prior year primarily reflecting a goodwill impairment charge of $511 million, recorded during the quarter. This charge was due to the decrease in the price per share of the Company’s common stock related to a number of factors including recent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.